Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 5 Esophageal Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Neoplasms 3 Head and Neck Neoplasms 3 Prostatic Neoplasms 2 Phyllodes Tumor 2 Carcinoma, Squamous Cell 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Thymoma 1 Stomach Neoplasms 1 Sarcoma 1 Postoperative Complications 1 Oropharyngeal Neoplasms 1 Neoplastic Cells, Circulating 1 Mouth Neoplasms 1 Lymphatic Metastasis 1 Liver Neoplasms 1 Laryngeal Neoplasms 1 Laryngeal Diseases 1 High-Risk Cancer 1 Endometrial Neoplasms 1 Carcinoma, Lobular 1 Carcinoma, Hepatocellular 1 Breast Cancer Radiotherapy 1

Interventions

Letrozole 6 Radiotherapy 4 Carboplatin 4 atamestane 3 Trastuzumab 3 Toremifene 3 Magnetic Resonance Spectroscopy 3 Fulvestrant 3 Docetaxel 3 Cyclophosphamide 3 Chemotherapy, Adjuvant 3 Tamoxifen 2 Paclitaxel 2 Gene Expression Profiling 2 Estrogen Receptor Modulators 2 Capecitabine 2 Aromatase Inhibitors 2 Amplified Fragment Length Polymorphism Analysis 2 repotrectinib 1 proto-oncogene protein c-fes-fps 1 palbociclib 1 neratinib 1 gallium 68 PSMA-11 1 fluciclovine F-18 1 entrectinib 1 Zolpidem 1 Vorinostat 1 Vinorelbine 1 Venlafaxine Hydrochloride 1 Thiotepa 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Lobular × Radiotherapy, Adjuvant × Clear all

NCT07613151 2026-05-29

NAPOLI

Istituto Oncologico Veneto IRCCS

Neoplasms, Carcinoma, Lobular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡